In the last trading session, the stock price of Endo International plc – Ordinary Shares (NASDAQ:ENDP) jumped more than 13% to close the day at
GenMark Diagnostics, Inc (NASDAQ:GNMK) issued financial report for the third quarter closed September 30, 2017. During the reported quarter, the company placed 65 ePlex® analyzers,
Plug Power Inc (NASDAQ:PLUG) reported a new deal with Toyota Material Handling Norway to offer hydrogen fuel cells to Asko, a major Norwegian grocery wholesaler.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported certain preliminary data for the quarter closed September 30, 2017, including anticipated: (i) revenues of around $785
Nokia Oyj (ADR)(NYSE:NOK) reported a strategic deal with Amazon Web Services, Inc. that will boost the migration of service provider apps to the cloud and
Dextera Surgical Inc (NASDAQ:DXTR) reported that numerous major surgeons featured the application of Dextera Surgical’s MicroCutter 5/80™ Stapler as well as its C-Port® Distal Anastomosis
In the last trading session, the stock price of Neothetics Inc (NASDAQ:NEOT) declined more than 22% to close the day at $1.33. There is no
Evofem Biosciences, Inc. and Neothetics Inc (NASDAQ:NEOT) have finalized a definitive deal under which the former firm will merge with a 100% owned subsidiary unit
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported the conclusion of a pre-planned futility assessment of the Phase III TIVO-3 study, the firm’s randomized, controlled, open-label trial to
Traders News Source released a report with no obligation on ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC), a firm that is advancing immune-based therapies targeting brain diseases and
Avinger Inc (NASDAQ:AVGR) a key developer of unique treatments for Peripheral Artery Disease reported Conformité Européenne Marking approval for curing in-stent restenosis using the Pantheris®
Genocea Biosciences Inc (NASDAQ:GNCA) reported that it is laying off nearly 40 of its 100 employees and intending to unload a genital herpes vaccine plan
The 22nd Century Group Inc (NYSEMKT:XXII) has made an announcement outlining that it has come to the end of the 2013 Research License and Commercial
As the third quarter winds down, market participants are beginning to see a move toward a diffusion of capital by larger fund managers. Higher nominal
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced recently the receipt of over $4 million research and development related payment from EUSA Pharma to facilitate the approval of
In the last trading session, the stock price of Endo International plc – Ordinary Shares (NASDAQ:ENDP) jumped more than 13% to close the day at
GenMark Diagnostics, Inc (NASDAQ:GNMK) issued financial report for the third quarter closed September 30, 2017. During the reported quarter, the company placed 65 ePlex® analyzers,
Plug Power Inc (NASDAQ:PLUG) reported a new deal with Toyota Material Handling Norway to offer hydrogen fuel cells to Asko, a major Norwegian grocery wholesaler.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported certain preliminary data for the quarter closed September 30, 2017, including anticipated: (i) revenues of around $785
Nokia Oyj (ADR)(NYSE:NOK) reported a strategic deal with Amazon Web Services, Inc. that will boost the migration of service provider apps to the cloud and
Dextera Surgical Inc (NASDAQ:DXTR) reported that numerous major surgeons featured the application of Dextera Surgical’s MicroCutter 5/80™ Stapler as well as its C-Port® Distal Anastomosis
In the last trading session, the stock price of Neothetics Inc (NASDAQ:NEOT) declined more than 22% to close the day at $1.33. There is no
Evofem Biosciences, Inc. and Neothetics Inc (NASDAQ:NEOT) have finalized a definitive deal under which the former firm will merge with a 100% owned subsidiary unit
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported the conclusion of a pre-planned futility assessment of the Phase III TIVO-3 study, the firm’s randomized, controlled, open-label trial to
Traders News Source released a report with no obligation on ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC), a firm that is advancing immune-based therapies targeting brain diseases and
Avinger Inc (NASDAQ:AVGR) a key developer of unique treatments for Peripheral Artery Disease reported Conformité Européenne Marking approval for curing in-stent restenosis using the Pantheris®
Genocea Biosciences Inc (NASDAQ:GNCA) reported that it is laying off nearly 40 of its 100 employees and intending to unload a genital herpes vaccine plan
The 22nd Century Group Inc (NYSEMKT:XXII) has made an announcement outlining that it has come to the end of the 2013 Research License and Commercial
As the third quarter winds down, market participants are beginning to see a move toward a diffusion of capital by larger fund managers. Higher nominal
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced recently the receipt of over $4 million research and development related payment from EUSA Pharma to facilitate the approval of
